Poster Presentations

ea0105p1 | Poster Presentations

Clinical outcomes of streptozocin (STZ) based chemotherapy in neuroendocrine tumours (NETs): a retrospective analysis of 26 patients from a single cancer centre - nottingham university hospitals (UK)

ea0105p2 | Poster Presentations

Insulinoma: an argument for rapid PRRT pathways in refractory disease

ea0105p3 | Poster Presentations

Primary hyperparathyroidism in multiple endocrine neoplasia type 1 (MEN1): Northern Ireland’s (N.I) experience

ea0105p4 | Poster Presentations

Leak rates in pancreatico-duodenectomy procedures in pancreatic NETs compared to pancreatic ductal adenocarcinoma resections

ea0105p5 | Poster Presentations

Management of cold sepsis in a patient receiving peptide radionuclide receptor treatment (PRRT): a case review

ea0105p6 | Poster Presentations

The experience of transarterial embolisation for metastsatic NET at queen Elizabeth Hospital Birmingham and future possible role of selective internal radiation therapy

ea0105p7 | Poster Presentations

Coeliac artery dissection in neuroendocrine neoplasms: coincidence or cause?

ea0105p8 | Poster Presentations

The indolent behaviour of type 1 gastric neuroendocrine tumours smaller than 1 cm: a single western center experience

ea0105p9 | Poster Presentations

Clinical outcomes of patients with rectal neuroendocrine tumours smaller than 10 mm after endoscopic resection

ea0105p10 | Poster Presentations

Testicular neuroendocrine tumour with carcinoid heart diseaseon the background of urological cancers: a trio of malignancies

ea0105p11 | Poster Presentations

Is there a role for post-operative functional imaging in small intestinal neuroendocrine tumours resected with curative intent?

ea0105p12 | Poster Presentations

From PRRT to liver transplant: redefining boundaries and navigating multimodal management of metastatic duodenal NET

ea0105p13 | Poster Presentations

A pilot model of group education for nutritional/dietary advice and symptom management in neuroendocrine neoplasms (NEN) (GEDNEN course interim analysis)

ea0105p14 | Poster Presentations

Treatment of MiNEN with peptide receptor radionuclide therapy

ea0105p15 | Poster Presentations

Impact of somatostatin analogues on SSTR expression and Ki-67 expression marker in LCC-18 neuroendocrine tumour cells

ea0105p16 | Poster Presentations

Case report: immunotherapy for a well-differentiated rectal neuroendocrine neoplasm

ea0105p17 | Poster Presentations

High prevalence of sarcopenia in patients with neuroendocrine tumours and carcinoid heart disease, but no effect on postoperative complications or survival

ea0105p18 | Poster Presentations

Retrospective audit evaluating outcomes in patients post resection for pancreatic neuroendocrine tumours

ea0105p19 | Poster Presentations

Systemic anti-cancer therapy in gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC): insights from national cancer registration and analysis service (NCRAS)

ea0105p20 | Poster Presentations

See the unseen: a rare presentation of metastatic small bowel NET with unilateral visual loss

ea0105p21 | Poster Presentations

Size, but not the number of positive lymph nodes is associated with worse overall survival in patients with small bowel neuroendocrine tumours

ea0105p22 | Poster Presentations

Advocacy in practice: pancreatic enzyme replacement therapy

ea0105p23 | Poster Presentations

Profound, durable benefit from external beam radiotherapy for primary, in transit and locoregional disease from Merkel cell carcinoma in the frail elderly: illustrative clinical vignettes

ea0105p24 | Poster Presentations

Challenging diagnosis of intra-pancreatic splenunculus mimicking neuroendocrine tumour

ea0105p25 | Poster Presentations

Management of carcinoid flare events following peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumours (NET): our experience at the christie NHS foundation trust

ea0105p26 | Poster Presentations

Challenges in diagnosis and treatment in an evolving pancreatic neuroendocrine tumour

ea0105p27 | Poster Presentations

Multifocal small bowel neuroendocrine tumours – experience of a single clinical centre

ea0105p28 | Poster Presentations

Case series: tuberous sclerosis associated pancreatic neuroendocrine tumours at a tertiary centre

ea0105p29 | Poster Presentations

Phaeochromocytoma associated with neurofibromatosis type 1: a single tertiary care centre experience

ea0105p30 | Poster Presentations

Malnourished patients with GEP-NETs, how does this develop in 5 years

ea0105p31 | Poster Presentations

Retrospective study evaluating factors influencing cancer recurrence following surgical resection of pancreatic neuroendocrine tumours (PanNETs)

ea0105p32 | Poster Presentations

Perioperative short-acting somatostatin analogue use in patients undergoing neuroendocrine tumour excision – do we need a change in guidelines?

ea0105p33 | Poster Presentations

Endocrine Abstracts

UKI NETS 22nd National Conference

22nd Annual Meeting of the UK and Ireland Neuroendocrine Tumour Society 2024

Clinical outcomes of streptozocin (STZ) based chemotherapy in neuroendocrine tumours (NETs): a retrospective analysis of 26 patients from a single cancer centre - nottingham university hospitals (UK)

Insulinoma: an argument for rapid PRRT pathways in refractory disease

Primary hyperparathyroidism in multiple endocrine neoplasia type 1 (MEN1): Northern Ireland’s (N.I) experience

Leak rates in pancreatico-duodenectomy procedures in pancreatic NETs compared to pancreatic ductal adenocarcinoma resections

Management of cold sepsis in a patient receiving peptide radionuclide receptor treatment (PRRT): a case review

The experience of transarterial embolisation for metastsatic NET at queen Elizabeth Hospital Birmingham and future possible role of selective internal radiation therapy

Coeliac artery dissection in neuroendocrine neoplasms: coincidence or cause?

The indolent behaviour of type 1 gastric neuroendocrine tumours smaller than 1 cm: a single western center experience

Clinical outcomes of patients with rectal neuroendocrine tumours smaller than 10 mm after endoscopic resection

Testicular neuroendocrine tumour with carcinoid heart diseaseon the background of urological cancers: a trio of malignancies

Is there a role for post-operative functional imaging in small intestinal neuroendocrine tumours resected with curative intent?

From PRRT to liver transplant: redefining boundaries and navigating multimodal management of metastatic duodenal NET

A pilot model of group education for nutritional/dietary advice and symptom management in neuroendocrine neoplasms (NEN) (GEDNEN course interim analysis)

Treatment of MiNEN with peptide receptor radionuclide therapy

Impact of somatostatin analogues on SSTR expression and Ki-67 expression marker in LCC-18 neuroendocrine tumour cells

Case report: immunotherapy for a well-differentiated rectal neuroendocrine neoplasm

High prevalence of sarcopenia in patients with neuroendocrine tumours and carcinoid heart disease, but no effect on postoperative complications or survival

Retrospective audit evaluating outcomes in patients post resection for pancreatic neuroendocrine tumours

Systemic anti-cancer therapy in gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC): insights from national cancer registration and analysis service (NCRAS)

See the unseen: a rare presentation of metastatic small bowel NET with unilateral visual loss

Size, but not the number of positive lymph nodes is associated with worse overall survival in patients with small bowel neuroendocrine tumours

Advocacy in practice: pancreatic enzyme replacement therapy

Profound, durable benefit from external beam radiotherapy for primary, in transit and locoregional disease from Merkel cell carcinoma in the frail elderly: illustrative clinical vignettes

Challenging diagnosis of intra-pancreatic splenunculus mimicking neuroendocrine tumour

Management of carcinoid flare events following peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumours (NET): our experience at the christie NHS foundation trust

Challenges in diagnosis and treatment in an evolving pancreatic neuroendocrine tumour

Multifocal small bowel neuroendocrine tumours – experience of a single clinical centre

Case series: tuberous sclerosis associated pancreatic neuroendocrine tumours at a tertiary centre

Phaeochromocytoma associated with neurofibromatosis type 1: a single tertiary care centre experience

Malnourished patients with GEP-NETs, how does this develop in 5 years

Retrospective study evaluating factors influencing cancer recurrence following surgical resection of pancreatic neuroendocrine tumours (PanNETs)

Perioperative short-acting somatostatin analogue use in patients undergoing neuroendocrine tumour excision – do we need a change in guidelines?

Hidden hypoglycemia: a case series on diagnosing insulinomas

BiosciAbstracts